Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy

CAMBRIDGE, Mass., Feb. 28, 2023 -- (Healthcare Sales & Marketing Network) -- Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, today announced a four-year global research collaboration with Vertex Pharmaceuticals I... Biopharmaceuticals Tevard Biosciences, Vertex Pharmaceuticals, Duchenne muscular dystrophy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news